Skip to content
Friday, October 9, 2026
Explore curated digital archives and historical insights at…

TikTok Content Creators Driving Unofficial Trade for Unlicensed Slimming Medication

A shadow market for unapproved weight-loss medications is propelled by TikTok fitness influencers and sellers on communication apps, according to recent findings.

Investigational Treatment Gaining Popularity Online

Retatrutide, which is still in research studies, is being promoted by online personalities for its alleged weight-reducing effects. Viewers are encouraged to message these accounts directly for source information, while also receiving promotional offers.

Active Commerce on Social Networks

Separately, a robust trade exists on messaging services, where communities with numerous of members share “before and after” images, injection guides and claims of next-day UK delivery. Vendors promote the drug there before redirecting buyers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an experimental injection developed by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist patients reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Professionals Voice Concerns

Nevertheless, doctors and chemists have cautions that the sale of what is still an unapproved medication in the UK is worrisome and could lead to individuals injecting substances of unknown origin.

Some professionals stated the popularity for retatrutide could be connected to the increasing cost of approved weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unapproved medication that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Several influencers try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate pharmaceutical, marketing, and consumer regulations, risking penalties, legal action or imprisonment.

Service Response and Content Elimination

According to TikTok, the service has taken down violative content and prohibited related hashtags and query recommendations. The organization said it was dedicated to keeping the platform safe and investing in strengthening compliance measures.

Online Marketplace Operations

Research also discovered communities with up to 9,000 participants marketing the experimental drug using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly displays groups with numerous of users, populated with photos of weight loss, positive testimonials and step-by-step guides for preparing or injecting at residence.

After minutes of joining one community, a seller shared WhatsApp details, where the majority of transactions occur. The vendor provided an instruction manual and guaranteed shipping within two days. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one inquired about body mass, health issues or past usage.

Product Details and Costs

Within these communities, posts display dark colored parcels with postal service labels, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with sterile water, or ready-to-use injectors typically priced at £160 for 20mg. When asked how much time a injector should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A representative for the messaging service stated it regularly moderated harmful material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are injecting substances they cannot confirm. Even if the research behind retatrutide is valid, these online versions may not include what they claim,” stated a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices increasing, individuals are using online platforms. But counterfeit treatments are extremely risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained.

Her team has previously seen individuals injured by personal administration from unverified sources. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated the doctor. “These substances could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly stated the substance was in third stage research studies and had not been evaluated or authorized by any government authority globally. “Consequently at this time no one can market [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a company investigational substance not yet authorized … may expose patients to potentially significant medical dangers”.

About the author

Michael Ward

Digital archivist and historian specializing in preserving cultural heritage through innovative curation methods.

Neat Archive

Type to search articles.